Ehrlichia equi infection of horses from Minnesota and Wisconsin: detection of seroconversion and acute disease investigation.
Equine granulocytic ehrlichiosis (EGE) is caused by infection with Ehrlichia equi. EGE has been reported primarily in northern California, where E equi is transmitted by the tick Ixodes pacificus. Reports of EGE and the emergence of human granulocytic ehrlichia in Minnesota prompted a seroprevalence study of E equi in horses of Minnesota and Wisconsin. Tick (Ixodes scapularis) endemic areas of Minnesota and Wisconsin were compared to nonendemic regions of Minnesota. Indirect fluorescent antibody was used to detect the presence of serum antibodies to E equi. Serum samples from healthy horses, 375 samples from I scapularis endemic counties, and 366 samples from nonendemic counties were screened at a 1:40 dilution. Results demonstrated a seroprevalence of 17.6% in endemic areas versus 3.8% in nonendemic areas. Ehrlichial DNA from 2 samples was successfully amplified by polymerase chain reaction and 919 base pairs were sequenced. The DNA sequence of 1 Minnesota/Wisconsin strain differed from the GenBank strain (M73223) of E equi at positions 84 and 886 and from the MRK strain of E equi at position 84, and was identical to the human granulocytic ehrlichiosis (HGE) agent. The 2nd Minnesota/Wisconsin strain was identical to the 1st with the exception of a substitution of "A" at position 453 that is not present in E phagocytophila, E equi, or HGE agent strain sequences. Based on the results of this study, we concluded that E equi is present and causes infection in horses in Minnesota and Wisconsin. The occurrence of infection is higher in tick endemic regions.
Bullock
P M
PM
Department of Clinical and Population Sciences, College of Veterinary Medicine, University of Minnesota, St Paul, USA. bullo003@tc.umn.edu
Ames
T R
TR
Robinson
R A
RA
Greig
B
B
Mellencamp
M A
MA
Dumler
J S
JS
D000208:Acute Disease; D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood*; D001483:Base Sequence; D004269:DNA, Bacterial / Q000097:blood / Q000737:chemistry; D004275:DNA, Ribosomal / Q000737:chemistry; D004536:Ehrlichia / Q000235:genetics* / Q000276:immunology*; D016873:Ehrlichiosis / Q000453:epidemiology / Q000276:immunology / Q000662:veterinary*; D005260:Female; D006734:Horse Diseases / Q000453:epidemiology* / Q000276:immunology / Q000382:microbiology; D006736:Horses; D006801:Humans; D018884:Ixodes; D008297:Male; D008910:Minnesota / Q000453:epidemiology; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction / Q000662:veterinary; D012329:RNA, Bacterial / Q000097:blood*; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D016415:Sequence Alignment / Q000662:veterinary; D017422:Sequence Analysis, DNA / Q000662:veterinary; D016036:Seroepidemiologic Studies; D013984:Tick Infestations / Q000453:epidemiology; D014922:Wisconsin / Q000453:epidemiology
D000907:Antibodies, Bacterial; D004269:DNA, Bacterial; D004275:DNA, Ribosomal; D012329:RNA, Bacterial; D012336:RNA, Ribosomal, 16S